BCL9L and colorectal carcinoma: Additionally, cells that experience chronic Wnt signalling, including APC-mutant CRC cells are refractory to Tankyrase inhibition, due to the significant expression of BCL9l and LEF1 which shield β-catenin from AXIN-mediated destruction23.